Correspondence and offprint requests to: Jaume Almirall; E-mail: jalmirall@tauli.cat Abstract Background. Vitamin D and calcium metabolism are involved in vascular smooth muscle cell proliferation, endothelial function and blood pressure (BP) regulation. Their physiopathology has been a matter of intensive clinical investigation with variable and sometimes contradictory results. Vitamin D insufficiency is highly prevalent in the general population, particularly among the elderly. We evaluated the association between serum 25(OH)-D levels and arterial BP in this population.
Introduction
The prevalence of vitamin D deficiency in the general population varies widely, but is consistently high worldwide, mainly among the elderly. Most reported values range from 24% to 70% [1, 2] . Although there is no consensus on optimal serum levels of 25(OH)-D, the minimum desirable levels have been suggested to be 20-30 ng/ml [3] .
While better characterized consequence of vitamin D deficiency involves the musculoskeletal system and bone metabolism, with compromised bone mineral density, falls and fractures [4, 5] , epidemiological studies have also demonstrated its relationship with other disorders such as infectious disease, inflammatory process and some kinds of cancers [6] [7] [8] [9] [10] . Recently, interest has also focussed on the relationship of vitamin D deficiency with the presence of metabolic syndrome, diabetes mellitus [11] , cardiovascular disease [12] [13] [14] and particularly with arterial hypertension [15] .
This wide diversity of effects is not surprising as the vitamin D receptor has a broad tissue distribution that includes the endothelium, vascular smooth muscle and cardiomyocytes.
Recently, a directly inhibitory effect of activated vitamin D on renin synthesis has been clearly demonstrated in the experimental animal [16] . In addition, vitamin D can regulate the expression of the natriuretic peptide receptor [17] . All of these effects can influence systemic blood pressure (BP). Epidemiological data have associated low skin exposure to ultraviolet B radiation, which is the major source of vitamin D, with higher BP [18] . Nevertheless, although there is a trend towards a negative association between measured serum vitamin D levels and BP, clinical reports are sometimes inconsistent, showing positive and negative associations.
In this study, we analysed the association between measured serum 25(OH)-D and BP in a representative sample of the population over 64 years of age in our reference area.
Subjects and methods
A cross-sectional study was carried out on the population over 64 years of age residing in the reference area of the Corporació Parc Taulí, a hospital located in Sabadell, near Barcelona (Spain) with a reference area of over 400 000 inhabitants, ∼11% of whom are over 64. The study was primarily designed to analyse the prevalence of hypovitaminosis D in this area (D'AVIS study: [19] ) and was approved by the Hospital's Clinical Research Ethics Committee and the Scientific Committee of the Fundació Gol i Gorina of the Institut Català de la Salut.
Sample and inclusion criteria
Five representative primary health care areas (PHCA) were selected and a proportional random sample was drawn from each. The estimated total sample size, based on an estimated prevalence of 25%, a 6% precision and a risk of 0.05, included 250 subjects, who were randomly selected from the Central Registry of Insured Persons for each PHCA. Only individuals over 64 years of age were recruited for the study. Exclusion criteria included any of the following conditions: diseases with a possible relation to vitamin D metabolism: known chronic renal insufficiency or creatinine ≥1.4 mg/dl; inflammatory gastrointestinal pathology or malabsorption syndrome, neoplasms, alcohol intake >40 g/day; current treatment with vitamin D supplements; and long-term institutionalization or residing in nursing homes (96% had a Barthel scale over 90).
Sources of information and variables
The study was initiated after obtaining informed consent. The analysis was performed during the first quarter of the year (January-March). The following general and medical items were included in the questionnaire: age, sex, BP, weight and height, main antecedents, previous cardiovascular events, diabetes, dyslipidaemia and administered medications. Three BP measurements were obtained by an experienced nurse after sitting at rest for 5 min, and the mean of the final two readings was used in the analysis. Measurements were obtained with a validated automatic device (OMRON M6) or with a mercury sphygmomanometer. The body mass index (BMI) was obtained by the formula: weight (kg)/height 2 (cm), and obesity was defined when BMI was >30. Blood samples were taken from candidates, and the following analytical determinations were obtained: calcium, urea, creatinine, 25(OH)-D, intact parathyroid hormone (iPTH) and serum albumin. Blood calcium values were adjusted according to the level of blood albumin levels, using the following formula: total blood calcium + (4.5 -total blood albumin) × 0.8. Serum 25(OH)-D was quantified by radioimmunoassay that measures 25(OH)-D 3 (DiaSorin, Stillwater, MN, USA, reference values 8-80 ng/ml, variation coefficient 9.4-11%) and iPTH by the chemiluminescence method (Elecsys Roche, Penzberg, Germany, reference values 15-65 pg/ml, variation coefficient 2.6-3.1%). Hypertension was defined when BP was >140/ 90 mmHg or hypotensive medication was administered. Vitamin D hypovitaminosis was defined as serum 25(OH)-D <25 ng/ml, as this was the level at which iPTH started to rise with a 95% sensibility to detect secondary hyperparathyroidism. The glomerular filtration rate was estimated with the MDRD formula [20] .
Statistical analyses
The data obtained was registered in ACCESS and processed using the SPSS 15.0 statistical package. A descriptive analysis was performed, and the results were expressed as median ± standard deviation. A univariate analysis was then carried out to identify associations between systolic and diastolic BP with the different variables (Mann-Whitney test for categorical variables, or Spearman correlation for continuous variables).
Next, multiple lineal regression analysis techniques were used to test the independent association between 25(OH)-D categories and BP. Systolic and diastolic BP were taken as dependent variables after controlling for those variables that were clinically or statistically significant, or that could be considered as a confounding factor (age, gender, ischaemic events, antihypertensive treatment, obesity, diabetes and dyslipidaemia).
The alpha risk was set at 5% for all estimations.
Results
A total of 554 subjects were contacted by phone. After excluding 317 (refusal to participate, not localized, not keeping the appointment or with exclusion criteria), 237 subjects were included in the study. The mean age was 71.7 ± 5.3 years (between 64 and 93), and 53% were females. The baseline clinical and biochemical characteristics of the study population are given in Table 1 . The mean BP values were 138.8 ± 14.3 and 80 ± 7.4 mmHg for systolic and diastolic BP, respectively, and 46% of patients were on antihypertensive medication. The mean serum 25(OH)-D levels were 17.2 ± 7.5 ng/ml (interval 5-54). The distribution of 25(OH)-D levels are represented in Figure 1 , and 86% had hypovitaminosis. The mean iPTH was 60 ± 26 pg/ml (32% had iPTH >65 pg/ml, the upper normal limit), with a mean corrected Ca: 9.7 ± 0.43 mg/dl (8. higher iPTH. Figure 2 represents the correlation between 25(OH)-D and iPTH values (r = −0.3; P < 0.001).
As antihypertensive treatment modifies BP, the results are also represented according to this variable. Figure 3A and B represents the correlation between BP (systolic and diastolic) and 25(OH)-D levels, splitting the sample according to whether patients were on antihypertensive treatment or not. This correlation is observed in both groups, though slightly higher in the non-treated group. Table 2 shows the association of BP with different clinical and biological variables. We wish to point out that systolic BP was significantly associated with low 25(OH)-D levels (r = −0.153, P = 0.018 when analysed as continuous variables). Diastolic BP was found to be associated with 25(OH)-D (r = −0.152; P = 0.019 when analysed as continuous variables), iPTH, age, body mass index, antihypertensive treatment, diabetes and previous ischaemic event.
In the multivariate analyses (Table 3) , low 25(OH)-D levels were significantly and independently associated with a 6.6 mmHg increase in systolic BP (95% CI: 1.5-11.6) after controlling for the other variables (F = 3.9; P = 0.000; r 2 corrected = 0.092). This association was lost in relation to diastolic BP, although other variables such as age and diabetes maintained the association.
Discussion
The results of the present study suggest an inverse association between serum 25(OH)-D levels and BP. Although a direct cause-effect cannot be extrapolated from this kind of observational studies, several arguments make this inverse association plausible. Furthermore, the persistence of the association after adjusting for confounding factors in the multivariate analysis strengthens the results.
Data from epidemiological studies suggest that conditions that decrease vitamin D synthesis in the skin, such as dark skin and living in temperate latitudes, are associated with increased prevalence of arterial hypertension [18] . Also, a seasonal variation in BP has been shown, peaking in winter and falling in summer [21] . Although Spain is a sunny country, our results demonstrate a high prevalence (86%) of hypovitaminosis D among the population over 64 years of age, at least in winter. Other studies in Spanish samples have reported similar results [22] .
Several potential mechanisms can explain the association of vitamin D deficiency with higher BP. Although the relationship between circulating levels of vitamin D and renin activity linkage was previously suggested in essential clinical hypertension studies [23] , it has just recently been demonstrated that 1.25(OH)2-D directly modulates the renin-angiotensin system [16] .
Other potential mechanisms could be related to the effects of vitamin D on vascular smooth muscle cell growth, inflammation and thrombosis [24] . In addition, in vitro studies have suggested that vitamin D can regulate the activity and expression of the type A natriuretic peptide receptor [17] . Finally, vitamin D deficiency is involved in secondary hyperparathyroidism, and parathyroid hormone has been proved to have unfavourable cardiovascular effects, promoting arterial hypertension, left ventricular hypertrophy and cardiac fibrosis [25] .
Due to the wide prevalence of hypovitaminosis in the general population, it seems logical to introduce active measures to improve the situation. Nevertheless, the effects of increasing vitamin D levels on BP have been a matter of conflicting results. A controlled clinical trial found that exposure to UVB radiation three times weekly for 6 weeks during the winter increased serum 25(OH)-D levels and significantly decreased 24-h ambulatory BP by an average of 6 mmHg [26] . A combination of 800 IU/day of vitamin D and 1200 mg/day of calcium for 8 weeks significantly decreased systolic BP in elderly women by 9% compared to calcium alone [27] . Nevertheless, in other studies, supplementation with 400 IU/day or a single dose of 100 000 IU of vitamin D did not significantly lower BP in elderly people over the following 2 months [28] . In this way, a recent prospective 10-year follow-up study found that intakes of low fat dairy products, calcium and vitamin D supplements were each inversely associated with risk of hypertension. Nevertheless, as the authors state, this association was diet related and lost in individuals who took calcium and vitamin D supplements [29] .
Results of cross-sectional analysis of 'dietary vitamin D intake' and BP have also been conflicting [30, 31] . Forman et al. examined the association between intake of vitamin D and the risk of incident hypertension among participants of three large and independent prospective cohorts: Nurses Health Study I, Nurses Health Study II and Health Professionals' Follow-up Study; and no association was found [32] . In contrast, the same author, in a more recent study [15] , prospectively analysed the association between 'measured plasma 25(OH)-D' or 'predicted' 25(OH)-D levels and risk of incident hypertension in a subgroup of the two previous prospective cohort studies concluding that plasma 25(OH)-D levels were inversely associated with risk of incident hypertension.
These results can be coherent with the minimal amount of vitamin D contained in a normal diet, and the small contribution of vitamin D intake to circulating 25(OH)D levels [33] . In our study, hypovitaminosis D was not related with dietary habits or calculated vitamin D ingestion. In fact, the only determinant of serum 25 (OH)-D levels was sun exposure [19] .
Independently from BP effects, considerable clinical interest has also focussed on the effects of vitamin D on the cardiovascular system in general. Several clinical studies suggest that low 25(OH)-D levels increase the risk of a cardiovascular event in the general population [13, 14, 34, 35] . Similar results have been observed in chronic renal failure patients [36] [37] [38] . In the same way, observational studies in dialysis have described a better survival in patients treated with vitamin D derivates [36, 39, 40] . All this evidence suggests that vitamin D has a protective role in the cardiovascular and renal systems. In our study, we did not observe an association between 25(OH)-D and the presence of a previous clinical ischaemic event. This may be due to the cross-sectional design and the bias of the study population analysed. It is important to bear in mind that these results were obtained in a selected group of people with good functional capacity (96% had a Barthel scale >90). In a recent study by Wang et al. [14] that reported data on 1739 Framingham Offspring Study participants without prior cardiovascular disease, after a follow-up of 5.4 years, they observed that vitamin D deficiency was associated with incident cardiovascular events. Interestingly, this association was observed in participants with hypertension but not in normotensives.
Our study has some important limitations as it is merely a cross-sectional analysis, and the possibility that vitamin D deficiency may act as a 'marker' of a non-specific illness rather than directly determine the hypertensive state cannot be ruled out. Nevertheless, the cohort studied represents a selection of the healthy population over age 64, as chronically ill and institutionalized patients were excluded. Our strengths include the strict protocol of BP measurements and the absence of seasonal fluctuations of vitamin D, as all samples were collected within a 3-month period. This is of utmost importance as that the seasonal fluctuation of 25(OH)-D is well known.
In conclusion, we have found that there is a high prevalence of hypovitaminosis D in the elderly population in our reference area, and that serum 25(OH)-D levels are inversely correlated with BP. Supplemental measures to prevent hypovitaminosis D in this population should be taken, not only to protect the skeletal system but also for the possible beneficial effects on cardiovascular and BP regulation, although further research is needed in this area.
